Molecular Targets and Promising Therapeutics of Triple-Negative Breast Cancer

por Ryu, Won-Ji, Sohn, Joo Hyuk
Publicado 2021

Multi-Disciplinary Treatment of a Rare Pelvic Cavity Ependymoma

por Hwang, Hye Jin, Sohn, Joo Hyuk, Han, Seung Jin, Kim, Tai Seung, Lee, Youn Soo, Kim, Joo Hang
Publicado 2007

Machine Learning Predicts Pathologic Complete Response to Neoadjuvant Chemotherapy for ER+HER2- Breast Cancer: Integrating Tumoral and Peritumoral MRI Radiomic Features

por Park, Jiwoo, Kim, Min Jung, Yoon, Jong-Hyun, Han, Kyunghwa, Kim, Eun-Kyung, Sohn, Joo Hyuk, Lee, Young Han, Yoo, Yangmo
Publicado 2023

Chemoradiotherapy with or without consolidation chemotherapy using cisplatin and 5-fluorouracil in anal squamous cell carcinoma: long-term results in 31 patients

por Cho, Byoung Chul, Ahn, Joong Bae, Seong, Jinsil, Roh, Jae Kyung, Kim, Joo Hang, Chung, Hyun Cheol, Sohn, Joo Hyuk, Kim, Nam Kyu
Publicado 2008

Management of Abemaciclib‐Associated Adverse Events in Patients with Hormone Receptor‐Positive, Human Epidermal Growth Factor Receptor 2‐Negative Advanced Breast Cancer: Safety Ana...

por Rugo, Hope S., Huober, Jens, García‐Sáenz, José A., Masuda, Norikazu, Sohn, Joo Hyuk, Andre, Valerie A.M., Barriga, Susana, Cox, Joanne, Goetz, Matthew
Publicado 2020

Destabilization of β-catenin and RAS by targeting the Wnt/β-catenin pathway as a potential treatment for triple-negative breast cancer

por Ryu, Won-Ji, Lee, Jeong Dong, Park, Jong-Chan, Cha, Pu-Hyeon, Cho, Yong-Hee, Kim, Jee Ye, Sohn, Joo Hyuk, Paik, Soonmyung, Choi, Kang-Yell
Publicado 2020

Do Recent Advances in Diagnostic and Therapeutic Procedures Negate the Benefit of Postmastectomy Radiotherapy in N1 Patients With a Low Risk of Locoregional Recurrence?

por Chang, Jee Suk, Lee, Jeongshim, Kim, Kyung Hwan, Sohn, Joo Hyuk, Kim, Seung Il, Park, Byeong-Woo, Chung, Hyun Cheol, Keum, Ki Chang, Suh, Chang-Ok, Kim, Yong Bae
Publicado 2015

Establishment of chemosensitivity tests in triple-negative and BRCA-mutated breast cancer patient-derived xenograft models

por Park, Hyung Seok, Lee, Jeong Dong, Kim, Jee Ye, Park, Seho, Kim, Joo Heung, Han, Hyun Ju, Choi, Yeon A., Choi, Ae Ran, Sohn, Joo Hyuk, Kim, Seung Il
Publicado 2019

Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations

por Lee, Jii Bum, Jung, Minkyu, Beom, Seung Hoon, Kim, Gun Min, Kim, Hye Ryun, Choi, Hye Jin, Sohn, Joo Hyuk, Ahn, Joong Bae, Rha, Sun Young, Chung, Hyun Cheol
Publicado 2021

Olaparib monotherapy for Asian patients with a germline BRCA mutation and HER2-negative metastatic breast cancer: OlympiAD randomized trial subgroup analysis

por Im, Seock-Ah, Xu, Binghe, Li, Wei, Robson, Mark, Ouyang, Quchang, Yeh, Dah-Cherng, Iwata, Hiroji, Park, Yeon Hee, Sohn, Joo Hyuk, Tseng, Ling-Ming, Goessl, Carsten, Wu, Wenting, Masuda, Norikazu
Publicado 2020

A Pilot Study of Trans-Arterial Injection of (166)Holmium-Chitosan Complex for Treatment of Small Hepatocellular Carcinoma

por Cho, Byoung Chul, Kim, Eun Hee, Choi, Hye Jin, Kim, Joo Hang, Roh, Jae Kyung, Chung, Hyun Cheol, Ahn, Joong Bae, Lee, Jong Doo, Lee, Jong Tae, Yoo, Nae Choon, Sohn, Joo Hyuk
Publicado 2005

External validation of IBTR! 2.0 nomogram for prediction of ipsilateral breast tumor recurrence

por Lee, Byung Min, Chang, Jee Suk, Cho, Young Up, Park, Seho, Park, Hyung Seok, Kim, Jee Ye, Sohn, Joo Hyuk, Kim, Gun Min, Koo, Ja Seung, Keum, Ki Chang, Suh, Chang-Ok, Kim, Yong Bae
Publicado 2018

Randomized controlled trial of standardized education and telemonitoring for pain in outpatients with advanced solid tumors

por Kim, Han Sang, Shin, Sang Joon, Kim, Sang Cheol, An, Surim, Rha, Sun Young, Ahn, Joong Bae, Cho, Byoung Chul, Choi, Hye Jin, Sohn, Joo Hyuk, Kim, Hyo Song, Chung, Hyun Cheol, Kim, Joo Hang, Roh, Jae Kyung, Lee, Soohyeon
Publicado 2013

Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials

por Yen, Chia-Jui, Muro, Kei, Kim, Tae-Won, Kudo, Masatoshi, Shih, Jin-Yuan, Lee, Keun-Wook, Chao, Yee, Kim, Sang-We, Yamazaki, Kentaro, Sohn, JooHyuk, Cheng, Rebecca, Zhang, Yawei, Binder, Polina, Mi, Gu, Orlando, Mauro, Chung, Hyun Cheol
Publicado 2018

Outcomes of an Acute Palliative Care Unit at a Comprehensive Cancer Center in Korea

por Lee, Si Won, Kwon, Jung Hye, Beom, Seung-hoon, Shin, Sang Joon, Kim, Hyo Song, Rha, Sun Young, Jung, Minkyu, Sohn, Joo Hyuk, Ahn, Joong-Bae, Chung, Hyun Cheol, Kim, Gun Min, Kim, Hye Ryun, Kang, Beodeul, Hu, Youn Jung, Choi, Hye Jin
Publicado 2023

Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracyclin...

por Park, In Hae, Im, Seock-Ah, Jung, Kyung Hae, Sohn, Joo Hyuk, Park, Yeon Hee, Lee, Keun Seok, Sim, Sung Hoon, Park, Kyong-Hwa, Kim, Jee Hyun, Nam, Byung Ho, Kim, Hee-Jun, Kim, Tae-Yong, Lee, Kyung-Hun, Kim, Sung-Bae, Ahn, Jin-Hee, Lee, Suee, Ro, Jungsil
Publicado 2019

Prognostic Value of Axillary Nodal Ratio after Neoadjuvant Chemotherapy of Doxorubicin/Cyclophosphamide Followed by Docetaxel in Breast Cancer: A Multicenter Retrospective Cohort S...

por Kim, Se Hyun, Jung, Kyung Hae, Kim, Tae-Yong, Im, Seock-Ah, Choi, In Sil, Chae, Yee Soo, Baek, Sun Kyung, Kang, Seok Yun, Park, Sarah, Park, In Hae, Lee, Keun Seok, Choi, Yoon Ji, Lee, Soohyeon, Sohn, Joo Hyuk, Park, Yeon-Hee, Im, Young-Hyuck, Ahn, Jin-Hee, Kim, Sung-Bae, Kim, Jee Hyun
Publicado 2016

An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Pacli...

por Park, In Hae, Sohn, Joo Hyuk, Kim, Sung Bae, Lee, Keun Seok, Chung, Joo Seop, Lee, Soo Hyeon, Kim, Tae You, Jung, Kyung Hae, Cho, Eun Kyung, Kim, Yang Soo, Song, Hong Suk, Seo, Jae Hong, Ryoo, Hun Mo, Lee, Sun Ah, Yoon, So Young, Kim, Chul Soo, Kim, Yong Tai, Kim, Si Young, Jin, Mi Ryung, Ro, Jungsil
Publicado 2017

Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced...

por Bidard, Francois-Clement, Kaklamani, Virginia G., Neven, Patrick, Streich, Guillermo, Montero, Alberto J., Forget, Frédéric, Mouret-Reynier, Marie-Ange, Sohn, Joo Hyuk, Taylor, Donatienne, Harnden, Kathleen K., Khong, Hung, Kocsis, Judit, Dalenc, Florence, Dillon, Patrick M., Babu, Sunil, Waters, Simon, Deleu, Ines, García Sáenz, José A., Bria, Emilio, Cazzaniga, Marina, Lu, Janice, Aftimos, Philippe, Cortés, Javier, Liu, Shubin, Tonini, Giulia, Laurent, Dirk, Habboubi, Nassir, Conlan, Maureen G., Bardia, Aditya
Publicado 2022

Integrative modeling of tumor genomes and epigenomes for enhanced cancer diagnosis by cell-free DNA

por Bae, Mingyun, Kim, Gyuhee, Lee, Tae-Rim, Ahn, Jin Mo, Park, Hyunwook, Park, Sook Ryun, Song, Ki Byung, Jun, Eunsung, Oh, Dongryul, Lee, Jeong-Won, Park, Young Sik, Song, Ki-Won, Byeon, Jeong-Sik, Kim, Bo Hyun, Sohn, Joo Hyuk, Kim, Min Hwan, Kim, Gun Min, Chie, Eui Kyu, Kang, Hyun-Cheol, Kong, Sun-Young, Woo, Sang Myung, Lee, Jeong Eon, Ryu, Jai Min, Lee, Junnam, Kim, Dasom, Ki, Chang-Seok, Cho, Eun-Hae, Choi, Jung Kyoon
Publicado 2023